Revance Therapeutic (RVNC) PT Lowered to $35 at Needham & Company

September 20, 2023 7:23 AM EDT Send to a Friend

Needham & Company analyst Serge ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Revance Therapeutic (RVNC) PT Lowered to $35 at Needham & Company

Member Login

Free News Feed